Molecule Details
| InChIKey | CMPJAGCXBOHFAF-UHFFFAOYSA-N |
|---|---|
| Compound Name | N-[3-[(1-ethyl-3,3,5-trimethyl-2,4-dioxo-1,5-benzodiazepin-7-yl)oxy]propyl]-N-[2-(1-oxoisoquinolin-2-yl)ethyl]benzenesulfonamide |
| Canonical SMILES | CCN1C(=O)C(C)(C)C(=O)N(C)c2cc(OCCCN(CCn3ccc4ccccc4c3=O)S(=O)(=O)c3ccccc3)ccc21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.35 |
| Source | ChEMBL |
2D Structure
Activity Profile